NCT01537692: Clinical Study to Evaluate the Pharmacokinetics and Safety of BDP HFA Nasal Aerosol |
|
|
| Completed | 1 | 30 | US | BDP HFA Nasal Aerosol, BDP HFA Inhalation Aerosol (QVAR) | Teva Branded Pharmaceutical Products R&D, Inc. | Allergic Rhinitis | 04/09 | 06/09 | | |
2006-006736-22: An early diagnosis of asthma in young children by using non-invasive biomarkers of oxidative stress/airway inflammation, and early lung function measurements |
|
|
| | 1 | 200 | Europe | Qvar Extrafijne Aerosol 100 inhalator, Qvar Extrafijne Aerosol 100 inhalator | Netherlands Asthma Foundation (NAF), Stichting astma bestrijding | children with recurrent respiratory symptoms) | | | | |
